DE60214987D1 - Mittel gegen posttraumatische stresszustände - Google Patents
Mittel gegen posttraumatische stresszuständeInfo
- Publication number
- DE60214987D1 DE60214987D1 DE60214987T DE60214987T DE60214987D1 DE 60214987 D1 DE60214987 D1 DE 60214987D1 DE 60214987 T DE60214987 T DE 60214987T DE 60214987 T DE60214987 T DE 60214987T DE 60214987 D1 DE60214987 D1 DE 60214987D1
- Authority
- DE
- Germany
- Prior art keywords
- raumatic
- post
- stress states
- against post
- ptsd
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 208000028173 post-traumatic stress disease Diseases 0.000 abstract 4
- 102100035842 Prostaglandin E2 receptor EP1 subtype Human genes 0.000 abstract 2
- 239000000556 agonist Substances 0.000 abstract 2
- GMVPRGQOIOIIMI-UHFFFAOYSA-N (8R,11R,12R,13E,15S)-11,15-Dihydroxy-9-oxo-13-prostenoic acid Natural products CCCCCC(O)C=CC1C(O)CC(=O)C1CCCCCCC(O)=O GMVPRGQOIOIIMI-UHFFFAOYSA-N 0.000 abstract 1
- 108010088540 Prostaglandin E receptors Proteins 0.000 abstract 1
- 102000008866 Prostaglandin E receptors Human genes 0.000 abstract 1
- 101150058615 Ptger1 gene Proteins 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 229960000711 alprostadil Drugs 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- XEYBRNLFEZDVAW-ARSRFYASSA-N dinoprostone Chemical compound CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1C\C=C/CCCC(O)=O XEYBRNLFEZDVAW-ARSRFYASSA-N 0.000 abstract 1
- 229960002986 dinoprostone Drugs 0.000 abstract 1
- 229940043274 prophylactic drug Drugs 0.000 abstract 1
- GMVPRGQOIOIIMI-DWKJAMRDSA-N prostaglandin E1 Chemical compound CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(O)=O GMVPRGQOIOIIMI-DWKJAMRDSA-N 0.000 abstract 1
- XEYBRNLFEZDVAW-UHFFFAOYSA-N prostaglandin E2 Natural products CCCCCC(O)C=CC1C(O)CC(=O)C1CC=CCCCC(O)=O XEYBRNLFEZDVAW-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
- A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Orthopedics, Nursing, And Contraception (AREA)
- Saccharide Compounds (AREA)
- Excavating Of Shafts Or Tunnels (AREA)
- Steroid Compounds (AREA)
- Forging (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2001075398 | 2001-03-16 | ||
| JP2001075398 | 2001-03-16 | ||
| PCT/JP2002/002513 WO2002076505A1 (fr) | 2001-03-16 | 2002-03-15 | Remedes pour trouble de stress post-traumatique |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DE60214987D1 true DE60214987D1 (de) | 2006-11-09 |
| DE60214987T2 DE60214987T2 (de) | 2007-09-06 |
Family
ID=18932485
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE60214987T Expired - Lifetime DE60214987T2 (de) | 2001-03-16 | 2002-03-15 | Mittel gegen posttraumatische stresszustände |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US20040122100A1 (de) |
| EP (1) | EP1374899B1 (de) |
| JP (1) | JPWO2002076505A1 (de) |
| AT (1) | ATE340577T1 (de) |
| CA (1) | CA2440710C (de) |
| DE (1) | DE60214987T2 (de) |
| WO (1) | WO2002076505A1 (de) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2305304A4 (de) * | 2008-04-28 | 2011-08-10 | Nat University Corp Hamamatsu University School Of Medicine | Immunstimulator mit ep1-agonist |
| CA2860453C (en) | 2011-01-24 | 2020-04-28 | Inceptum Research & Therapeutics, Inc. | Compositions comprising a prostaglandin for treating neuropsychiatric conditions |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4123568B2 (ja) * | 1998-05-06 | 2008-07-23 | 小野薬品工業株式会社 | ６−オキソ−ｐｇｅ１化合物、それらの製造方法およびそれらを有効成分として含有するプロスタグランジンｅ２受容体作働薬 |
| WO2004082517A2 (en) * | 2003-03-19 | 2004-09-30 | Bar Ilan University | Animal exhibiting ptsd-like behavior, per pct rule 4.3 |
-
2002
- 2002-03-15 AT AT02705269T patent/ATE340577T1/de not_active IP Right Cessation
- 2002-03-15 DE DE60214987T patent/DE60214987T2/de not_active Expired - Lifetime
- 2002-03-15 JP JP2002575017A patent/JPWO2002076505A1/ja active Pending
- 2002-03-15 WO PCT/JP2002/002513 patent/WO2002076505A1/ja active IP Right Grant
- 2002-03-15 EP EP02705269A patent/EP1374899B1/de not_active Expired - Lifetime
- 2002-03-15 CA CA002440710A patent/CA2440710C/en not_active Expired - Fee Related
- 2002-03-15 US US10/471,805 patent/US20040122100A1/en not_active Abandoned
-
2005
- 2005-10-14 US US11/249,484 patent/US20060058394A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EP1374899B1 (de) | 2006-09-27 |
| EP1374899A4 (de) | 2004-11-17 |
| JPWO2002076505A1 (ja) | 2004-07-15 |
| CA2440710C (en) | 2009-08-18 |
| WO2002076505A1 (fr) | 2002-10-03 |
| ATE340577T1 (de) | 2006-10-15 |
| EP1374899A8 (de) | 2004-03-10 |
| US20040122100A1 (en) | 2004-06-24 |
| EP1374899A1 (de) | 2004-01-02 |
| DE60214987T2 (de) | 2007-09-06 |
| US20060058394A1 (en) | 2006-03-16 |
| CA2440710A1 (en) | 2002-10-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR9917007A (pt) | Moduladores de ccr5 | |
| EA200300999A1 (ru) | Хронотерапевтические дозированные формы | |
| DE60212163D1 (de) | Kontrolliertes wirkstoffabgabesystem | |
| AR034881A1 (es) | Mezcla insecticida | |
| BRPI0210335B8 (pt) | copolímero de blocos, e, composição | |
| ATE541587T1 (de) | Konjugat-additionsreaktionen zur kontrollierten abgabe von pharmazeutisch wirksamen substanzen | |
| CL2008003391A1 (es) | Compuestos derivados de pirrolidinas, moduladores de la funcion del receptor de androgeno (divisional de la solicitud 970-03). | |
| DE60217121D1 (de) | Medikament enthaltender klebstoff | |
| DE60224284D1 (de) | Stabile formulierung von modifiziertem glp-1 | |
| NO20052474L (no) | Amort form av esomeprazolsalter | |
| RS50814B (sr) | Tartaratne soli 5,8,14-triazatetraciklo(10.3.1.02,11.04,9)- heksadeka-2(11),3,5,7,9-pentaena | |
| ATE334663T1 (de) | Arzneimittelzusammensetzung mit verzögerter wirkstoffabgabe | |
| NO20033918L (no) | Ny anvendelse av peptidklasse av forbindelser for behandling av allodyni eller andre typer av kronisk smerte eller fantomsmerte | |
| ATE433989T1 (de) | Pharmazeutisch wirksame uridinester | |
| NO20065836L (no) | Linezolidkrystallform | |
| ATE530197T1 (de) | Medizinische zusammensetzungen zur angiogenese- therapie | |
| BR9916575A (pt) | Composição farmacêutica de liberação controlada com mesilato de tilidina como substância-ativa | |
| PT1358177E (pt) | Tratamento de desordens afectivas atraves da accao combinada de um agonista do receptor nicotinico e uma substancia manoaminergica | |
| DE69913116D1 (de) | Orale flüssige lösung enthaltend das antidepressivum mirtazapine | |
| ITMI20001093A0 (it) | Composizioni a rilascio controllato contenenti un principio attivo, preferibilmente melatonina, e processo di preparazione delle stesse. | |
| EA200501697A1 (ru) | Дозируемая форма, содержащая пантопразол в качестве активного ингредиента | |
| CY1105345T1 (el) | Φαινυλαλκινια | |
| DE60214987D1 (de) | Mittel gegen posttraumatische stresszustände | |
| EA200300727A1 (ru) | Производные 2h-1-бензопирана, способы их получения и их фармацевтические композиции | |
| BRPI0406734A (pt) | Composição termiticida, e, método para controlar térmitas |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8381 | Inventor (new situation) |
Inventor name: NARUMIYA, SHUH, KYOTO, JP Inventor name: MARUYAMA, TAKAYUKI, MISHIMA, OSAKA, JP |
|
| 8364 | No opposition during term of opposition |